|
Aug 2
|
Pharming Group Second Quarter 2025 Earnings: EPS: US$0.007 (vs US$0.002 loss in 2Q 2024)
|
|
Aug 1
|
New Strong Buy Stocks for August 1st
|
|
Jul 31
|
European Equities Traded in the US as American Depositary Receipts Falling Thursday
|
|
Jul 31
|
Pharming Group reports second quarter and first half 2025 financial results and provides business update
|
|
Jul 29
|
High Growth Tech Stocks To Watch In Europe July 2025
|
|
Jul 25
|
Best Momentum Stocks to Buy for July 25th
|
|
Jul 22
|
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics
|
|
Jul 22
|
Preeclampsia Drug Market Research Report 2025-2035 | Competitive Analysis of Pharming Group, AMAG Pharmaceuticals, Kyowa Kirin, and Baxter
|
|
Jul 17
|
Best Momentum Stocks to Buy for July 17th
|
|
Jul 17
|
New Strong Buy Stocks for July 17th
|
|
Jul 17
|
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
|
|
Jul 15
|
Uncovering Opportunities: AROBS Transilvania Software And 2 Other Promising European Penny Stocks
|
|
Jun 24
|
Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
|
|
Apr 25
|
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
|
|
Apr 25
|
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?
|
|
Apr 24
|
Pharming announces positive recommendation from NICE for Joenja
|
|
Apr 24
|
Pharming Group to report first quarter 2025 financial results on May 8
|
|
Apr 23
|
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
|
|
Apr 15
|
European Opportunities: 3 Penny Stocks With Market Caps Larger Than €10M
|
|
Mar 14
|
Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|